|
Volumn 42, Issue 5, 1997, Pages 430-431
|
Systemic mastocytosis: Report of a case evolving into myelofibrosis and non-responsive to interferon αIIb;Mastocitosis sistemica: Presentacion de un caso con evolucion a mielofibrosis y nula respuesta a interferon αIIb
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA2B INTERFERON;
ANTIHISTAMINIC AGENT;
KETOTIFEN;
PREDNISONE;
BIOLOGICAL RESPONSE MODIFIER;
ADULT;
CASE REPORT;
FEMALE;
HUMAN;
LETTER;
MYELOFIBROSIS;
SYSTEMIC MASTOCYTOSIS;
TREATMENT FAILURE;
BONE MARROW;
BRAIN HEMORRHAGE;
FATALITY;
MASTOCYTOSIS;
MIDDLE AGED;
MULTIMODALITY CANCER THERAPY;
PATHOLOGY;
PROGNOSIS;
SPLENECTOMY;
BIOLOGICAL RESPONSE MODIFIERS;
BONE MARROW;
CEREBRAL HEMORRHAGE;
COMBINED MODALITY THERAPY;
FATAL OUTCOME;
FEMALE;
HISTAMINE ANTAGONISTS;
HUMANS;
INTERFERON ALFA-2B;
KETOTIFEN;
MASTOCYTOSIS;
MIDDLE AGED;
MYELOFIBROSIS;
PREDNISONE;
PROGNOSIS;
SPLENECTOMY;
|
EID: 0031244020
PISSN: 00364355
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
Times cited : (5)
|
References (10)
|